98297806 - SAIL

Information

  • Trademark
  • 98297806
  • Serial Number
    98297806
  • Filing Date
    December 04, 2023
    a year ago
  • Transaction Date
    December 17, 2024
    5 days ago
  • Status Date
    December 04, 2024
    18 days ago
  • Published for Opposition Date
    November 05, 2024
    a month ago
  • Location Date
    October 02, 2024
    2 months ago
  • Status Code
    774
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SAUNDERS, ANDREA
  • Attorney Docket Number
    V03392000500
    Attorney Name
    CHRISTINA M. LICURSI
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4
Mark Identification
SAIL
Case File Statements
  • GS0051: Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism
  • GS0421: Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals
Case File Event Statements
  • 12/4/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/28/2024 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/2/2024 - 5 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/2/2024 - 5 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/2/2024 - 5 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/25/2024 - 2 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/25/2024 - 2 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/25/2024 - 2 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/26/2024 - 2 months ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/16/2024 - 2 months ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/5/2024 - a month ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/5/2024 - a month ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/2/2024 - 5 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/4/2024 - 18 days ago
    14 - OPPOSITION PAPERS RECEIVED AT TTAB Type: OPPF
  • 12/4/2024 - 18 days ago
    15 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I